Sign In
Buy REGN
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
Cramer's First Take: Regeneron's not been treated with respect
09:49am, Monday, 08'th Nov 2021
CNBC's Jim Cramer joins 'Squawk Box' to discuss Regeneron's latest news and how the company has been treated as a whole.
Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose
09:21am, Monday, 08'th Nov 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has announced additional results from a Phase 3 trial, which assessed a single dose of REGEN-COV (1,200 mg administered via 4 subcutaneous injections) t
Regeneron says single dose of Covid antibody cocktail provides long-term protection
08:32am, Monday, 08'th Nov 2021
Regeneron says a single dose of its antibody cocktail reduced the risk of contracting Covid-19 by 81.6%. CNBC's 'Squawk Box' reports.
Regeneron says its COVID-19 antibody cocktail can prevent COVID-19 infections for months
07:31am, Monday, 08'th Nov 2021
Shares of Regeneron Pharmaceuticals Inc. REGN, -5.57% gained 3.7% in premarket trading on Monday after the company said four subcutaneous injections of its monoclonal antibody treatment protected unva
Billions Wiped From Covid Pharma Heavyweights—Including Moderna, Regeneron, Merck—As Pfizer's Antiviral Pill Triggers Selloff
10:26am, Friday, 05'th Nov 2021
Pfizer jumped 8% Friday morning, while Moderna dropped 17.8%, Regeneron 6.2% and Merck 9%.
3 Reasons Why Investors Should Love Regeneron's Q3 Update
06:01am, Friday, 05'th Nov 2021
The big biotech delivered an exceptionally strong performance in Q3.
Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q3 2021 Results - Earnings Call Transcript
01:49pm, Thursday, 04'th Nov 2021
Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q3 2021 Results - Earnings Call Transcript
Regeneron (REGN) Q3 Earnings Beat, REGEN-COV Boosts Growth
12:59pm, Thursday, 04'th Nov 2021
Regeneron (REGN) beats on Q3 earnings while sales record strong year-over-year growth on the solid performance of Dupixent and Eylea, and incremental contribution from REGEN-COV.
4 Health Care Stocks For Your November 2021 Watchlist
12:30pm, Thursday, 04'th Nov 2021
Could these health care stocks be buys on President Biden's latest vaccine mandate?
Regeneron Stock Slips Despite Earnings, Revenue Beat
10:33am, Thursday, 04'th Nov 2021
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) threw its hat into the earnings ring this morning, reporting third-quarter earnings and revenue that trounced Wall Street's estimates.
Why Regeneron Shares Are Rising Today
09:24am, Thursday, 04'th Nov 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is trading higher Thursday after the company announced better-than-expected third-quarter financial results. Regeneron reported quarterly adjusted earnings
Regeneron quarterly profit nearly doubles on strong demand for eczema drug
06:42am, Thursday, 04'th Nov 2021
Regeneron Pharmaceuticals Inc's third-quarter profit nearly doubled on Thursday, helped by robust demand for its blockbuster drugs Dupixent to treat eczema and eye treatment Eylea.
Is Regeneron Pharmaceuticals (REGN) Outperforming Other Medical Stocks This Year?
01:00pm, Wednesday, 03'rd Nov 2021
Is (REGN) Outperforming Other Medical Stocks This Year?
Will Eylea, Dupixent, REGEN COV Aid Regeneron (REGN) Q3 Earnings?
11:29am, Monday, 01'st Nov 2021
Regeneron's third-quarter performance might have gotten a boost from the solid performance of Eylea and Dupixent and incremental contribution from its antibody cocktail.
4 Big Drug, Biotech Stocks Set to Beat Q3 Earnings Estimates
12:59pm, Friday, 29'th Oct 2021
Let us take a look at some drug/biotech stocks that are poised to beat on third-quarter earnings.
